Eli Lilly and Company (LLY) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Eli Lilly and Company's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
46.73
Weak
WeakModerateStrong
P/B Ratio
36.37
Weak
WeakModerateStrong
Earnings Yield
2.14%
Yield Trap
WeakModerateStrong
Profitability Health
2025Return on Equity
77.78%
Strong
WeakModerateStrong
Operating Margin
45.56%
Strong
WeakModerateStrong
Net Profit Margin
31.66%
Strong
WeakModerateStrong
Growth Indicators
2025Revenue Growth
44.70%
Strong
WeakModerateStrong
Net Income Growth
94.88%
Strong
WeakModerateStrong
EPS Growth
95.58%
Strong
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
1.58
Moderate
WeakModerateStrong
Quick Ratio
1.19
Moderate
WeakModerateStrong
Asset Turnover
0.58x
Moderate
WeakModerateStrong
Inventory Turnover
0.77x
Weak
WeakModerateStrong
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
0.93%
Weak
WeakModerateStrong
EV / Free Cash Flow
111.50x
Weak
WeakModerateStrong
Net Debt / EBITDA
1.27x
Moderate
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.866
Moderate
WeakModerateStrong
Return on Invested Capital
30.20%
Strong
WeakModerateStrong
Cash Conversion Cycle
401.89 days
Weak
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for LLY.
View Financial Statements